Literature DB >> 16352498

Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background.

Najah Khalifa1, Anne-Liis von Knorring.   

Abstract

AIM: To describe the symptoms, onset, heredity, pre-/perinatal events and socio-economic status in Tourette syndrome (TS) and other tic disorders.
METHODS: From a total population of 4479 children, 25 (0.6%) with TS, 58 (1.3%) with chronic motor/vocal tics (CMVT) and 214 (4.8%) with transient tics (TT) in the last year were found. A three-stage procedure was used: tic screening, telephone interview and clinical assessment. The TS group was compared with 25 children with TT and 25 controls without tics.
RESULTS: The mean age of the first symptoms of TS was significantly lower than the onset of CMVT. All except one with TS had contact with medical services. The tics of children with TS were significantly more severe than the tics of others. Younger age of onset of TS indicated more severe tics. Parents and siblings of children with TS had an increased prevalence of tic disorders, obsessive-compulsive behaviour (OCD), attention-deficit/hyperactivity disorder (ADHD) and depression. Eighty per cent had a first-degree relative with a psychiatric disorder. A non-significant increase with regards to reduced optimality score in the pre-, peri- or neonatal periods was found in children with TS compared to controls. No differences were found concerning socio-economic status.
CONCLUSION: Almost all children from a total population with TS have sought help from medical services. An increased prevalence of tics, OCD, depression or ADHD was found in the parents/siblings of children with TS, which draws attention to the importance of thorough investigation of family members.

Entities:  

Mesh:

Year:  2005        PMID: 16352498     DOI: 10.1111/j.1651-2227.2005.tb01837.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  39 in total

Review 1.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

Review 2.  Pimozide for tics in Tourette's syndrome.

Authors:  Tamara Pringsheim; Connie Marras
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

3.  Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.

Authors:  Mazlum Copur; Baki Arpaci; Turkay Demir; Halis Narin
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 4.  A Review and Update on Tourette Syndrome: Where Is the Field Headed?

Authors:  Aysegul Gunduz; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 5.  The prognosis of Tourette syndrome: implications for clinical practice.

Authors:  Nadiya Hassan; Andrea E Cavanna
Journal:  Funct Neurol       Date:  2012 Jan-Mar

6.  Clinical correlates of tourette's disorder across cultures: a comparative study between the United Arab Emirates and the United Kingdom.

Authors:  Valsamma Eapen; Mary M Robertson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 7.  Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies.

Authors:  Rachel Marsh; Tiago V Maia; Bradley S Peterson
Journal:  Am J Psychiatry       Date:  2009-05-15       Impact factor: 18.112

8.  Emotional development in children with tics: a longitudinal population-based study.

Authors:  P J Hoekstra; A J Lundervold; S A Lie; C Gillberg; Kerstin J Plessen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-10-13       Impact factor: 4.785

9.  Consanguineous Iranian kindreds with severe Tourette syndrome.

Authors:  Maria G Motlagh; Arshia Seddigh; Behnoosh Dashti; James F Leckman; Javad Alaghband-Rad
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

Review 10.  Clinical assessment of Tourette syndrome and tic disorders.

Authors:  Stephanie C Cohen; James F Leckman; Michael H Bloch
Journal:  Neurosci Biobehav Rev       Date:  2012-12-01       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.